Last reviewed · How we verify

NCT04927624

Transversus Abdominis Plane Block Versus Quoadratus Lumborum Block on Infants

Status unknown NA Last updated 16 June 2021
What this trial tests

NA trial testing transversus abdominis plane block in Transversus Abdominis Plane Block in 60 participants. Status unknown.

Timeline
1 June 2021
Primary endpoint
30 September 2021
15 October 2021

Quick facts

Lead sponsorSisli Hamidiye Etfal Training and Research Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 June 2021
Primary completion30 September 2021
Estimated completion15 October 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Who can join

Adults 1 Month to 12 Months, any sex, with Transversus Abdominis Plane Block or Quoadratus Lumborum Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

we aimed to compare the effects of TAPB and QLB on postoperative pain score and analgesic consumption in infants who underwent unilateral inguinal hernia surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of transversus abdominis plane block

Trials testing the same drug.

Other recruiting trials for Transversus Abdominis Plane Block

Currently open trials in the same condition.

Other Sisli Hamidiye Etfal Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04927624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing